SHANA CARMIN: Open Payments
NPI 1760569065 · ALEXANDRIA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 18 payments from 7 companies in 2025. Trend: 2023 $233 · 2024 $538 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $193 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Novo Nordisk Inc | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| PFIZER INC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: QULIPTA, UBRELVY, VRAYLAR, CAPLYTA, AIRSUPRA, Ozempic, Wegovy, BREZTRI.
Industry payments across IN — which companies pay providers there.
